3′-epimeric k-252a derivatives
US6451786B1 · kind B1 · utility
2Cited by
6References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 15, 2000 |
| Grant date | Sep 17, 2002 |
| Priority date | — |
| Expiry date | Feb 15, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H5/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds defined by the following general structure are disclosed: These compounds display pharmacological activities, including inhibition of tyrosine kinase activity and enhancement of the function and/or survival of trophic factor responsive cells, e.g., cholinergic neurons.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.